Navigation Links
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
Date:7/16/2008

VIENNA, Austria, July 16 /PRNewswire/ -- In the clinical phase I trial AFF001, AFFiRiS GmbH has now recruited the 24 Alzheimer patients planned for this trial. The trial aims to investigate the tolerability and safety of an innovative Alzheimer's vaccine (AFFITOPE AD01). In the trial, all patients have now been vaccinated at least once and have so far tolerated the vaccine extremely well. The treatment provides for four vaccinations administered at monthly intervals and is due to be fully completed by this October. The vaccine's tolerability can then be conclusively evaluated. So far the results indicate good tolerability for this Alzheimer's vaccine from AFFiRiS GmbH. It is on this basis that recruitment of further patients has already begun for the clinical trial of a second Alzheimer's vaccine by AFFiRiS.

Vienna-based AFFiRiS GmbH has announced the successful completion of patient recruitment for clinical phase I testing of its Alzheimer's vaccine AD01. The vaccine is being administered at the Vienna General Hospital (AKH) to 24 Alzheimer's patients at a mild to moderate stage of the disease. The patients are being vaccinated a total of four times over a three-month period. During this time, and over a further two months, the safety and tolerability of the vaccine is being investigated. A professional care network with the highest medical standards ensures the patients' health and well-being.

Commenting on the planned progression of the trial, Dr. Walter Schmidt, CEO of AFFiRiS GmbH says: "We have now treated the maximum number of patients for the first time. After the end of the trial in a few months' time, we will know whether the impression so far of our vaccine's good tolerability is confirmed. As patient interest in the last few months has grown significantly, we are delighted that we are already in a position to offer participation in clinical testing of our second Alzheimer's vaccine, AFFITOPE AD02. The support from our largest investo
'/>"/>

SOURCE AFFiRiS GmbH
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Callisto Reports on Second-Quarter 2007 Milestones
2. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
5. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
8. Medarex to Receive Milestone Payment from Amgen
9. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Bionomics Achieves US$1 Million Milestone Payment from Genmab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...W YORK, Nov. 20 Clinical data from...e 35th Annual Veith Symposium shows DVT,treatment...om Bacchus,Vascular, Inc. (Santa Clara, CA) succe... in about 20 minutes. , This technique, cal...ores,blood flow more quickly and safely than curr...
(Date:11/19/2008)...N FRANCISCO, Nov. 19 Posit Science...idence at the Society for Neuroscience,Annual Con...t cognitive,training may benefit Baby Boomers. T...ess Program (TM) uses adaptive exercises that targ...are designed to drive generalized,improvements in...
(Date:11/19/2008).... Jude scientists report basic findings on critica...g how to better treat an array of disorders , ...e/ -- Scientists at St. Jude Children,s Research ...of one of the body,s enzyme workhorses called calp...evers, calpains function in many cellular processe...
(Date:11/19/2008)...riggers $5 Million Payment from Roche- , , ...Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) tod...oal for its Phase 2 trial of R3487/MEM 3454, its l...ve impairment associated with schizophrenia (CIAS)...Phase 2 trial, triggering a $5.0 million payment f...
Breaking Medicine Technology:Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference 7180 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 1CEVA Group Plc Reports Quarter 3 2007 Results 7176 2CEVA Group Plc Reports Quarter 3 2007 Results 7176 3CEVA Group Plc Reports Quarter 3 2007 Results 7176 4Finding Ways for Seniors to Stay Safe Healthy and Home 7172 1Finding Ways for Seniors to Stay Safe Healthy and Home 7172 2Finding Ways for Seniors to Stay Safe Healthy and Home 7172 3First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 1First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 2First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD 1993 3
...007 - Xanthus,Pharmaceuticals, Inc today presented...clinical and pathological signs of chronic,disease...esentation,was made by Stephen J. Karlik, Ph.D., P... of Western Ontario, London, Ontario,together wit...the,59th American Academy of Neurology Meeting in ...
...nical (IND) In- Vitro,Studies for Promising Alzhei...) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV), a ...nce positive results were attained with its,late-s...l (SP-233),with well recognized in-vitro models. ...ect predictors,of clinical responses, laboratory a...
Other Medicine Technology:Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
(Date:11/22/2008)...o enough to protect themselves from stroke, heart ...News) -- It,s one of medicine,s mantras: If you ha...ill have a dramatic impact on your risk of stroke,...ople with high blood pressure still aren,t doing a...S. Centers for Disease Control and Prevention stud...
(Date:11/21/2008)... new therapies for preterm labor , , FRI...hey,ve found the switch that activates the uterine...ing that may lead to therapies for preterm labor. ... protein IP on the surface of these uterine muscle...egnancy. , But researchers from Dartmouth Medi...
(Date:11/21/2008)...v. 21 During a memoria... G. Rendell today remembered Lieutenant Governor C...ortant partner in public service, and a tireless a... "As the first woman elected lieutenant governor, ... said Governor Rendell. "Her family and her faith ...
(Date:11/21/2008)...l proved effective against Lennox-Gastaut syndrome... A new drug called Banzel (rufinamide) has been ap...orm of epilepsy called Lennox-Gastaut syndrome, th...ay. , The approval was based on results of a fo...s 4 to 30. Compared to patients who took a placebo...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...AIDS in the early 1990's when she was 35, healthy,...d years earlier// of AIDS related complications, h...her less than two years to live. One day, flippi...eople, she saw an advertisement offering to buy he...
...a close friend of President Bush, a businessman-...itchman// on the president's health care proposals...th costs. He is promoting Bush's proposals to prov...... and make hospitals and doctors prices availabl...
...atisfied with their health care despite the fact t... other industrialized nations//. These were the re...d on Tuesday. In 2004 the survey revealed that Un... on medical care almost twice as much as other ind...
...iting crowd of 80,000 and the humid weather, the f... can feel cheerful about here are a spruced up// a...one-day cricket match between England and India ta...ernational Stadium Thursday. The teams were given ...
Other Medicine News:
The NU-5510 DHD AutoFlow Direct Heat Decontamination CO2 Incubator provides continuous HEPA filtration guarantying the greatest control of airborne contaminants. The dual decontamination cycles, both
...al-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...ss, convection air circulation optimizes culture c...al viewing window means cultures need not be distu...
...te-sized CO2 incubator with 6-sided direct heating...er-weight incubator with greater internal storage ...filtered CO2 inlet, heated outer door with glass i... optimize culture conditions and minimize contamin...
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO2 Incubator
Medicine Products: